NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Myungkyu Jang
Providence Health & Services - Renton / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 5312130
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Myungkyu Jang's MOST POPULAR ARTICLES
1-)
Design and discovery of an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancerF Shirai, A Mizutani, Y Yashiroda, T Tsumura, Y Kano, Y Muramatsu, ...Journal of Medicinal Chemistry 63 (8), 4183-4204, 2020302020
2-)
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancerT Mashima, Y Taneda, MK Jang, A Mizutani, Y Muramatsu, H Yoshida, ...Oncotarget 8 (29), 47902, 2017242017
3-)
Tankyrase inhibitors target colorectal cancer stem cells via axin-dependent downregulation of c-kit tyrosine kinaseMK Jang, T Mashima, H SeimiyaMolecular Cancer Therapeutics 19 (3), 765-776, 2020162020
4-)
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivoT Mashima, T Wakatsuki, N Kawata, MK Jang, A Nagamori, H Yoshida, ...Scientific Reports 11 (1), 15125, 2021102021
5-)
c-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cellsF Tomizawa, MK Jang, T Mashima, H SeimiyaBiochemical and Biophysical Research Communications 527 (4), 1014-1020, 202082020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept